99 related articles for article (PubMed ID: 12074714)
21. Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.
Dheekollu J; Malecka K; Wiedmer A; Delecluse HJ; Chiang AK; Altieri DC; Messick TE; Lieberman PM
Oncotarget; 2017 Jan; 8(5):7248-7264. PubMed ID: 28077791
[TBL] [Abstract][Full Text] [Related]
22. Undifferentiated nasopharyngeal carcinoma from a nonendemic area: protective role of HLA allele products presenting conserved EBV epitopes.
Pasini E; Caggiari L; Dal Maso L; Martorelli D; Guidoboni M; Vaccher E; Barzan L; Franchin G; Gloghini A; De Re V; Sacchi N; Serraino D; Carbone A; Rosato A; Dolcetti R
Int J Cancer; 2009 Sep; 125(6):1358-64. PubMed ID: 19536817
[TBL] [Abstract][Full Text] [Related]
23. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.
Shao JY; Huang XM; Yu XJ; Huang LX; Wu QL; Xia JC; Wang HY; Feng QS; Ren ZF; Ernberg I; Hu LF; Zeng YX
Anticancer Res; 2001; 21(4B):3021-9. PubMed ID: 11712805
[TBL] [Abstract][Full Text] [Related]
24. Association between EBNA2 and LMP1 subtypes of Epstein-Barr virus and nasopharyngeal carcinoma in Thais.
Tiwawech D; Srivatanakul P; Karalak A; Ishida T
J Clin Virol; 2008 May; 42(1):1-6. PubMed ID: 18180201
[TBL] [Abstract][Full Text] [Related]
25. Sequencing-based typing of HLA-B*51 alleles and the significant association of HLA-B*5101 and -B*5108 with Behçet's disease in Greek patients.
Mizuki N; Ota M; Katsuyama Y; Yabuki K; Ando H; Shiina T; Palimeris GD; Kaklamani E; Ito D; Ohno S; Inoko H
Tissue Antigens; 2002 Feb; 59(2):118-21. PubMed ID: 12028538
[TBL] [Abstract][Full Text] [Related]
26. HLA-B*51 allele analysis by the PCR-SBT method and a strong association of HLA-B*5101 with Japanese patients with Behçet's disease.
Mizuki N; Ota M; Katsuyama Y; Yabuki K; Ando H; Shiina T; Nomura E; Onari K; Ohno S; Inoko H
Tissue Antigens; 2001 Sep; 58(3):181-4. PubMed ID: 11703826
[TBL] [Abstract][Full Text] [Related]
27. Allelic distribution of HLA-B*5 in HLA-B5-positive Israeli patients with Behçet's disease.
Paul M; Klein T; Krause I; Molad Y; Narinsky R; Weinberger A
Tissue Antigens; 2001 Sep; 58(3):185-6. PubMed ID: 11703827
[TBL] [Abstract][Full Text] [Related]
28. Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter.
Zhang Y; Wang H; Liu Y; Wang C; Wang J; Long C; Guo W; Sun X
Biomed Pharmacother; 2018 Jun; 102():1003-1014. PubMed ID: 29710517
[TBL] [Abstract][Full Text] [Related]
29. Association of HLA-B51 subtypes and Behçet's disease in Spain.
González-Escribano MF; Rodríguez MR; Walter K; Sanchez-Roman J; García-Lozano JR; Núñez-Roldán A
Tissue Antigens; 1998 Jul; 52(1):78-80. PubMed ID: 9714478
[TBL] [Abstract][Full Text] [Related]
30. Are HLA-E*0103 alleles predictive markers for nasopharyngeal cancer risk?
Douik H; Romdhane NA; Guemira F
Pathol Res Pract; 2016 Apr; 212(4):345-9. PubMed ID: 26896927
[TBL] [Abstract][Full Text] [Related]
31. Expression of VCA (viral capsid antigen) and EBNA1 (Epstein-Barr-virus-encoded nuclear antigen 1) genes of Epstein-Barr virus in Pichia pastoris and application of the products in a screening test for patients with nasopharyngeal carcinoma.
Hu B; Hong G; Li Z; Xu J; Zhu Z; Li L
Biotechnol Appl Biochem; 2007 May; 47(Pt 1):59-69. PubMed ID: 17129209
[TBL] [Abstract][Full Text] [Related]
32. Contribution of susceptibility locus at HLA class I region and environmental factors to occurrence of nasopharyngeal cancer in Northeast India.
Lakhanpal M; Singh LC; Rahman T; Sharma J; Singh MM; Kataki AC; Verma S; Chauhan PS; Singh YM; Wajid S; Kapur S; Saxena S
Tumour Biol; 2015 Apr; 36(4):3061-73. PubMed ID: 25514873
[TBL] [Abstract][Full Text] [Related]
33. Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region.
Lu SJ; Day NE; Degos L; Lepage V; Wang PC; Chan SH; Simons M; McKnight B; Easton D; Zeng Y
Nature; 1990 Aug; 346(6283):470-1. PubMed ID: 2377207
[TBL] [Abstract][Full Text] [Related]
34. DNA typing of the HLA-A, -B and -C genes: possible MHC class I haplotypes in the northeastern-Thais.
Romphruk A; Leelayuwat C; Barusrux S; Puapairoj C; Romphruk A; Urwijitaroon Y
J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S13-9. PubMed ID: 9347640
[TBL] [Abstract][Full Text] [Related]
35. Polymorphism of the stress protein HSP70-2 gene is associated with the susceptibility to the nasopharyngeal carcinoma.
Jalbout M; Bouaouina N; Gargouri J; Corbex M; Ben Ahmed S; Chouchane L
Cancer Lett; 2003 Apr; 193(1):75-81. PubMed ID: 12691826
[TBL] [Abstract][Full Text] [Related]
36. Human leukocyte antigen (HLA) frequency among patients with nasopharyngeal carcinoma in Taiwan.
Wu SB; Hwang SJ; Chang AS; Hsieh T; Hsu MM; Hsieh RP; Chen CJ
Anticancer Res; 1989; 9(6):1649-53. PubMed ID: 2697183
[TBL] [Abstract][Full Text] [Related]
37. Lack of association between human leukocyte antigen-E alleles and nasopharyngeal carcinoma in Tunisians.
Hassen E; Ghedira R; Ghandri N; Farhat K; Gabbouj S; Bouaouina N; Abdelaziz H; Nouri A; Chouchane L
DNA Cell Biol; 2011 Aug; 30(8):603-9. PubMed ID: 21332388
[TBL] [Abstract][Full Text] [Related]
38. Leukocyte immunoglobulin-like receptor A3 gene deletion in five Chinese populations and protective association with nasopharyngeal carcinoma.
Tian W; Li LX; Cheng W; Jin HK; Zhang SS
Int J Immunogenet; 2024 Feb; 51(1):32-38. PubMed ID: 38015196
[TBL] [Abstract][Full Text] [Related]
39. HLA-DRB1 allele polymorphism and nasopharyngeal carcinoma risk: a meta-analysis.
Yao K; Yang S; Shen J; Zhang R; Li L
Eur Arch Otorhinolaryngol; 2017 Jan; 274(1):297-303. PubMed ID: 27535842
[TBL] [Abstract][Full Text] [Related]
40. Relationships of Human Leukocyte Antigen-A, -B, -DRB1 Alleles, and Haplotypes in 129 Ethnic Turkish Patients With Acute Myeloblastic Leukemia.
Patiroglu T; Akar HH
Lab Med; 2015; 46(3):195-9. PubMed ID: 26199258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
